Position in JNJ
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$41,296,283
+$3,581,636 QoQ
Shares Held
162,603
+5.4% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
1.17%
of 13F equity value
Holder Rank
#491
of 4,676 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 3%
Shared 0%
None 97%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NorthCrest Asset Manangement, LLC holds $171,430,810 across 12 Drug Manufacturers - General names. JNJ ranks #1 (24.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
162,603 | $41,296,283 | |
| 2 | AMGN |
Amgen Inc
|
73,601 | $26,652,394 | |
| 3 | ABBV |
AbbVie Inc.
|
100,564 | $25,305,924 | |
| 4 | LLY |
ELI LILLY & Co
|
17,429 | $20,904,867 | |
| 5 | MRK |
Merck & Co., Inc.
|
138,092 | $17,744,822 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
300,416 | $17,309,969 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
97,027 | $12,258,391 | |
| 8 | BIIB |
Biogen Inc.
|
25,857 | $5,586,663 |
All Filings in JNJ
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $41,296,283 | 162,603 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $37,714,647 | 154,290 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $52,018,124 | 251,356 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $46,524,103 | 250,912 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $37,534,799 | 245,727 | Shares | Sole | 2025-07-10 | |
| 2025-03-31 | $41,673,270 | 251,286 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $34,086,210 | 235,695 | Shares | Sole | 2025-03-17 | |
| 2024-09-30 | $37,730,647 | 232,819 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $33,425,184 | 228,689 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $35,580,411 | 224,922 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $34,122,768 | 217,703 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $36,512,005 | 234,427 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $38,433,081 | 232,196 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $36,103,530 | 232,926 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $33,424,653 | 189,214 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $32,197,602 | 197,096 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $34,269,724 | 193,058 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $31,839,901 | 179,653 | Shares | Sole | 2022-04-18 | |
| 2021-12-31 | $16,462,408 | 96,232 | Shares | Sole | 2022-02-09 | |
| No filing history on record for this holder in this stock. | ||||||